IntelliSpace Portal DX/HX/EX AutoSPECT Pro Software Application, Philips Medical Systems, Cleveland, OH. Provides software applications used to process, analyze, and display medical images/data.
Publicado el 27 de abril de 2016 · Inicio del retiro: 4 de marzo de 2016
Resumen
FDA registra el retiro Z-1506-2016 de dispositivos médicos de Clase II, publicado el 27 de abril de 2016 e iniciado el 4 de marzo de 2016. Empresa responsable: Philips Medical Systems (Cleveland) Inc; Estado: Finalizado; Cantidad reportada: 33 Units; Lote: M/N 881001; S/N: 85254, 82202, 85330, 82117, 7000022, 105009, 970001, 850001, 870030, 82141, 95068, 87182, 87197, 95078, 82140, 11017, 98139, 95035, 87200, 980047, 85314, 85303, 980046, 85298, 822022, 7000019, 950076, 950115, 95043, 95047, 950021, 960123 & 105006. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The AutoSPECT Pro application was only designed to reconstruct cardiac SPECT data obtained with detectors positioned at 90® or 180® relative to one another. However, certain gamma cameras allow for other relative detector angles. Data acquired at these other angles will not be correctly reconstructed by AutoSPECT Pro and the results will likely be erroneous.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Philips Medical Systems (Cleveland) Inc
- Distribuidor
- Worldwide Distribution -- US, including the states of CO, DE, FL, GA, IL, IN, KS, MO, NC, NV, NY, OH, OR, PA, TN & TX; and, the countries of Australia, Austria, Belgium, Canada, China, Denmark, Egypt, France, Germany, Greece, Ireland, Israel, Italy, Lebanon, Malaysia, Saudi Arabia, Slovenia, South Africa, Switzerland, Turkey, & United Kingdom.
- Lote
- M/N 881001; S/N: 85254, 82202, 85330, 82117, 7000022, 105009, 970001, 850001, 870030, 82141, 95068, 87182, 87197, 95078, 82140, 11017, 98139, 95035, 87200, 980047, 85314, 85303, 980046, 85298, 822022, 7000019, 950076, 950115, 95043, 95047, 950021, 960123 & 105006.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAPinnacle3 Radiation Therapy Planning System, Model numbers 870231 and 870237.21 de septiembre de 2022
- FDABrilliance 64 Model # 728231, computed tomography x-ray system14 de agosto de 2019
- FDAIngenuity Core128 Model # 728323, computed tomography x-ray system14 de agosto de 2019
- FDABrightView XCT , Model Number 88248231 de julio de 2019
- FDAExtended Brilliance Workspace NM Special Nuclear medicine image display and processing application suite.27 de abril de 2016
- FDAOssur Lil Angel Vest P3 Kodel. Pediatric sized vest is a support structure used with the halo system for27 de abril de 2016
Preguntas sobre este retiro
¿IntelliSpace Portal DX/HX/EX AutoSPECT Pro Software Application, Philips Medical Systems, Cleveland, OH. Provides software applications used to process, analyze, and display medical images/data. fue retirado del mercado?
Sí. FDA publicó el retiro Z-1506-2016 el 27 de abril de 2016. Peligro reportado: The AutoSPECT Pro application was only designed to reconstruct cardiac SPECT data obtained with detectors positioned at 90® or 180® relative to one another. However, certain gamma cameras allow for other relative detector angles. Data acquired at these other angles will not be correctly reconstructed by AutoSPECT Pro and the results will likely be erroneous.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter